{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:48:05Z","timestamp":1791920885950,"version":"4.3.4"},"reference-count":50,"publisher":"China Science Publishing & Media Ltd.","issue":"8","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2022,8,1]]},"DOI":"10.3724\/abbs.2022087","type":"journal-article","created":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T09:39:52Z","timestamp":1656927592000},"page":"1068-1079","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":10,"title":["Methyl 3,4-dihydroxybenzoate inhibits RANKL-induced osteoclastogenesis via Nrf2 signaling                     <italic>in vitro<\/italic> and suppresses LPS-induced osteolysis and ovariectomy-induced osteoporosis                     <italic>in vivo<\/italic>"],"prefix":"10.3724","volume":"54","author":[{"given":"Zhaobo","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenghui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengdong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2022,8,1]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cger.2016.08.003","volume":"33","author":"Alejandro P","year":"2017","unstructured":"Alejandro P, Constantinescu F. A review of osteoporosis in the older adult. Clin Geriatric Med, 2017, 33: 27-40.","journal-title":"Clin Geriatric Med"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1002\/jbmr.3757","volume":"34","author":"Zeng Q","year":"2019","unstructured":"Zeng Q, Li N, Wang Q, Feng J, Sun D, Zhang Q, Huang J. The prevalence of osteoporosis in China, a nationwide, multicenter DXA survey. J Bone Miner Res, 2019, 34: 1789-1797.","journal-title":"J Bone Miner Res"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.lers.2020.06.004","volume":"3","author":"He Y","year":"2020","unstructured":"He Y, Liu C, Huang Y. Can bone mineral density affect intra-operative blood loss of mini-invasive posterior lumbar interbody fusion?. Laparoscopic Endoscopic Robotic Surg, 2020, 3: 66-69.","journal-title":"Laparoscopic Endoscopic Robotic Surg"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1073\/pnas.96.7.3540","volume":"96","author":"Hsu H","year":"1999","unstructured":"Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E, Tan HL. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA, 1999, 96: 3540-3545.","journal-title":"Proc Natl Acad Sci USA"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00405-007-0459-x","volume":"265","author":"Topak M","year":"2008","unstructured":"Topak M, Oysu C, Yelken K, Sahin-Yilmaz A, Kulekci M. Laryngeal involvement in patients with active pulmonary tuberculosis. Eur Arch Otorhinolaryngol, 2008, 265: 327-330.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"12515","DOI":"10.1096\/fj.201802805RR","volume":"33","author":"An Y","year":"2019","unstructured":"An Y, Zhang H, Wang C, Jiao F, Xu H, Wang X, Luan W. Activation of ROS\/MAPK                         s \/NF\u2010                         \u03ba B\/NLRP3 and inhibition of efferocytosis in osteoclast\u2010mediated diabetic osteoporosis. FASEB J, 2019, 33: 12515-12527.","journal-title":"FASEB J"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"15003","DOI":"10.1038\/boneres.2015.3","volume":"3","author":"Tan J","year":"2015","unstructured":"Tan J, Xu X, Tong Z, Lin J, Yu Q, Lin Y, Kuang W. Decreased osteogenesis of adult mesenchymal stem cells by reactive oxygen species under cyclic stretch: a possible mechanism of age related osteoporosis. Bone Res, 2015, 3:","journal-title":"Bone Res"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1038\/ncomms4773","volume":"5","author":"Bartell SM","year":"2014","unstructured":"Bartell SM, Kim HN, Ambrogini E, Han L, Iyer S, Serra Ucer S, Rabinovitch P. FoxO proteins restrain osteoclastogenesis and bone resorption by attenuating H2O2 accumulation. Nat Commun, 2014, 5:","journal-title":"Nat Commun"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"4648","DOI":"10.7150\/thno.35414","volume":"9","author":"Liu Y","year":"2019","unstructured":"Liu Y, Wang C, Wang G, Sun Y, Deng Z, Chen L, Chen K. Loureirin B suppresses RANKL-induced osteoclastogenesis and ovariectomized osteoporosis via attenuating NFATc1 and ROS activities. Theranostics, 2019, 9: 4648-4662.","journal-title":"Theranostics"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"21706","DOI":"10.18632\/aging.103976","volume":"12","author":"Xiao L","year":"2020","unstructured":"Xiao L, Zhong M, Huang Y, Zhu J, Tang W, Li D, Shi J. Puerarin alleviates osteoporosis in the ovariectomy-induced mice by suppressing osteoclastogenesis via inhibition of TRAF6\/ROS-dependent MAPK\/NF-\u03baB signaling pathways. Aging, 2020, 12: 21706-21729.","journal-title":"Aging"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2020.01023","volume":"11","author":"Li M","year":"2020","unstructured":"Li M, Hao L, Li L, Liu L, Chen G, Jiang W, Xu W. Cinnamtannin B-1 prevents ovariectomy-induced osteoporosis via attenuating osteoclastogenesis and ROS generation. Front Pharmacol, 2020, 11:","journal-title":"Front Pharmacol"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1182\/blood-2004-09-3662","volume":"106","author":"Lee NK","year":"2005","unstructured":"Lee NK, Choi YG, Baik JY, Han SY, Jeong DW, Bae YS, Kim N. A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood, 2005, 106: 852-859.","journal-title":"Blood"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/4350965","volume":"2016","author":"Zhang J","year":"2016","unstructured":"Zhang J, Wang X, Vikash V, Ye Q, Wu D, Liu Y, Dong W. ROS and ROS-mediated cellular signaling. Oxid Med Cell Longev, 2016, 2016: 1-18.","journal-title":"Oxid Med Cell Longev"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"10797","DOI":"10.1038\/s41598-018-29122-1","volume":"8","author":"Florczyk-Soluch U","year":"2018","unstructured":"Florczyk-Soluch U, J\u00f3zefczuk E, St\u0119pniewski J, Bukowska-Strakova K, Mendel M, Viscardi M, Nowak WN. Various roles of heme oxygenase-1 in response of bone marrow macrophages to RANKL and in the early stage of osteoclastogenesis. Sci Rep, 2018, 8:","journal-title":"Sci Rep"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-00478-8","volume":"21","author":"Muri J","year":"2021","unstructured":"Muri J, Kopf M. Redox regulation of immunometabolism. Nat Rev Immunol, 2021, 21: 363-381.","journal-title":"Nat Rev Immunol"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","volume":"21","author":"Sies H","year":"2020","unstructured":"Sies H, Jones DP. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat Rev Mol Cell Biol, 2020, 21: 363-383.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.molmed.2019.09.007","volume":"26","author":"Dai X","year":"2020","unstructured":"Dai X, Yan X, Wintergerst KA, Cai L, Keller BB, Tan Y. Nrf2: redox and metabolic regulator of stem cell state and function. Trends Mol Med, 2020, 26: 185-200.","journal-title":"Trends Mol Med"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.freeradbiomed.2013.08.005","volume":"65","author":"Hyeon S","year":"2013","unstructured":"Hyeon S, Lee H, Yang Y, Jeong W. Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation. Free Radical Biol Med, 2013, 65: 789-799.","journal-title":"Free Radical Biol Med"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"111382","DOI":"10.1016\/j.biopha.2021.111382","volume":"137","author":"Su X","year":"2021","unstructured":"Su X, Guo W, Yuan B, Wang D, Liu L, Wu X, Zhang Y. Artesunate attenuates bone erosion in rheumatoid arthritis by suppressing reactive oxygen species via activating p62\/Nrf2 signaling. Biomed pharmacoTher, 2021, 137:","journal-title":"Biomed pharmacoTher"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3390\/md19030132","volume":"19","author":"Ha YJ","year":"2021","unstructured":"Ha YJ, Choi YS, Oh YR, Kang EH, Khang G, Park YB, Lee YJ. Fucoxanthin suppresses osteoclastogenesis via modulation of MAP kinase and Nrf2 signaling. Mar Drugs, 2021, 19:","journal-title":"Mar Drugs"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"e12882","DOI":"10.1111\/cpr.12882","volume":"53","author":"Ni S","year":"2020","unstructured":"Ni S, Qian Z, Yuan Y, Li D, Zhong Z, Ghorbani F, Zhang X. Schisandrin A restrains osteoclastogenesis by inhibiting reactive oxygen species and activating Nrf2 signalling. Cell Prolif, 2020, 53:","journal-title":"Cell Prolif"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.3389\/fphar.2020.01175","volume":"11","author":"Wang J","year":"2020","unstructured":"Wang J, Fang Z, Song C, Kang H, Guo Q, Dong Y, Zhang Y. Schisandrin b inhibits osteoclastogenesis and protects against ovariectomy-induced bone loss. Front Pharmacol, 2020, 11:","journal-title":"Front Pharmacol"},{"key":"CITATION23","unstructured":"Xu W, Gong X, Zhou X, Zhao C, Chen HJ. [Chemical constituents and bioactivity of Kalimeris indica].                                                      Zhongguo Zhong Yao Za Zhi                          2010, 35: 3172\u20133174."},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3390\/molecules21081071","volume":"21","author":"Cai L","year":"2016","unstructured":"Cai L, Wang LF, Pan JP, Mi XN, Zhang Z, Geng HJ, Wang JH. Neuroprotective effects of methyl 3,4-dihydroxybenzoate against TBHP-induced oxidative damage in SH-SY5Y cells. Molecules, 2016, 21:","journal-title":"Molecules"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1254\/jphs.13055FP","volume":"125","author":"Zhou X","year":"2014","unstructured":"Zhou X, Su CF, Zhang Z, Wang CY, Luo JQ, Zhou XW, Cai L. Neuroprotective effects of methyl 3,4-dihydroxybenzoate against H2O2-induced apoptosis in RGC-5 cells. J Pharmacol Sci, 2014, 125: 51-58.","journal-title":"J Pharmacol Sci"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/jnr.23235","volume":"91","author":"Zhou XW","year":"2013","unstructured":"Zhou XW, Zhang Z, Su CF, Lv RH, Zhou X, Cai L, Wang CY. Methyl 3,4-dihydroxybenzoate protects primary cortical neurons against A\u03b2                         25-35-induced neurotoxicity through mitochondria pathway. J Neurosci Res, 2013, 91: 1215-1225.","journal-title":"J Neurosci Res"},{"key":"CITATION27","unstructured":"Zhang Z, Zhou X, Zhou X, Xu X, Liao M, Yan L, Lv R, et al. Methyl 3,4-dihydroxybenzoate promotes neurite outgrowth of cortical neurons cultured                         in vitro.                                                      Neural Regen Res                         . 2012, 7: 971\u2013977."},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"5474","DOI":"10.3390\/molecules25225474","volume":"25","author":"Saha S","year":"2020","unstructured":"Saha S, Buttari B, Panieri E, Profumo E, Saso L. An overview of Nrf2 signaling pathway and its role in inflammation. Molecules, 2020, 25:","journal-title":"Molecules"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrrheum.2009.260","volume":"6","author":"Harvey N","year":"2010","unstructured":"Harvey N, Dennison E, Cooper C. Osteoporosis: impact on health and economics. Nat Rev Rheumatol, 2010, 6: 99-105.","journal-title":"Nat Rev Rheumatol"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"Boyle WJ","year":"2003","unstructured":"Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature, 2003, 423: 337-342.","journal-title":"Nature"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1126\/science.289.5484.1508","volume":"289","author":"Rodan GA","year":"2000","unstructured":"Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science, 2000, 289: 1508-1514.","journal-title":"Science"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","volume":"25","author":"Cosman F","year":"2014","unstructured":"Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R. Clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos Int, 2014, 25: 2359-2381.","journal-title":"Osteoporos Int"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.7150\/thno.30206","volume":"9","author":"Chen K","year":"2019","unstructured":"Chen K, Qiu P, Yuan Y, Zheng L, He J, Wang C, Guo Q. Pseurotin a inhibits osteoclastogenesis and prevents ovariectomized-induced bone loss by suppressing reactive oxygen species. Theranostics, 2019, 9: 1634-1650.","journal-title":"Theranostics"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"6393","DOI":"10.1158\/0008-5472.CAN-12-2664","volume":"72","author":"He J","year":"2012","unstructured":"He J, Liu Z, Zheng Y, Qian J, Li H, Lu Y, Xu J. p38 MAPK in myeloma cells regulates osteoclast and osteoblast activity and induces bone destruction. Cancer Res, 2012, 72: 6393-6402.","journal-title":"Cancer Res"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"ra54","DOI":"10.1126\/scisignal.2005867","volume":"8","author":"Lin J","year":"2015","unstructured":"Lin J, Lee D, Choi Y, Lee SY. The scaffold protein RACK1 mediates the RANKL-dependent activation of p38 MAPK in osteoclast precursors. Sci Signal, 2015, 8:","journal-title":"Sci Signal"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.3390\/ijms19103004","volume":"19","author":"Lee K","year":"2018","unstructured":"Lee K, Seo I, Choi MH, Jeong D. Roles of mitogen-activated protein kinases in osteoclast biology. Int J Mol Sci, 2018, 19:","journal-title":"Int J Mol Sci"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2004.12.041","volume":"120","author":"Kamata H","year":"2005","unstructured":"Kamata H, Honda SI, Maeda S, Chang L, Hirata H, Karin M. Reactive oxygen species promote TNF\u03b1-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell, 2005, 120: 649-661.","journal-title":"Cell"},{"key":"CITATION38","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1152\/physrev.00018.2001","volume":"82","author":"Dr\u00f6ge W","year":"2002","unstructured":"Dr\u00f6ge W. Free radicals in the physiological control of cell function. Physiol Rev, 2002, 82: 47-95.","journal-title":"Physiol Rev"},{"key":"CITATION39","doi-asserted-by":"publisher","first-page":"23863","DOI":"10.1074\/jbc.M803072200","volume":"283","author":"Jung Y","year":"2008","unstructured":"Jung Y, Kim H, Min SH, Rhee SG, Jeong W. Dynein light chain LC8 negatively regulates NF-\u03baB through the redox-dependent interaction with I\u03baB\u03b1. J Biol Chem, 2008, 283: 23863-23871.","journal-title":"J Biol Chem"},{"key":"CITATION40","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00401-017-1676-z","volume":"133","author":"Szepanowski F","year":"2017","unstructured":"Szepanowski F, Donaldson DM, Hartung HP, Mausberg AK, Kleinschnitz C, Kieseier BC, Stettner M. Dimethyl fumarate accelerates peripheral nerve regeneration via activation of the anti-inflammatory and cytoprotective Nrf2\/HO-1 signaling pathway. Acta Neuropathol, 2017, 133: 489-491.","journal-title":"Acta Neuropathol"},{"key":"CITATION41","doi-asserted-by":"publisher","first-page":"eaba1334","DOI":"10.1126\/sciadv.aba1334","volume":"6","author":"Lim J","year":"2020","unstructured":"Lim J, Heo J, Ju H, Shin JW, Kim YH, Lee S, Yu HY. Glutathione dynamics determine the therapeutic efficacy of mesenchymal stem cells for graft-versus-host disease via CREB1-NRF2 pathway. Sci Adv, 2020, 6:","journal-title":"Sci Adv"},{"key":"CITATION42","doi-asserted-by":"publisher","first-page":"101936","DOI":"10.1016\/j.redox.2021.101936","volume":"41","author":"Cen M","year":"2021","unstructured":"Cen M, Ouyang W, Zhang W, Yang L, Lin X, Dai M, Hu H. MitoQ protects against hyperpermeability of endothelium barrier in acute lung injury via a Nrf2-dependent mechanism. Redox Biol, 2021, 41:","journal-title":"Redox Biol"},{"key":"CITATION43","doi-asserted-by":"publisher","first-page":"101309","DOI":"10.1016\/j.redox.2019.101309","volume":"28","author":"Sun X","year":"2020","unstructured":"Sun X, Xie Z, Hu B, Zhang B, Ma Y, Pan X, Huang H. The Nrf2 activator RTA-408 attenuates osteoclastogenesis by inhibiting STING dependent NF-\u03bab signaling. Redox Biol, 2020, 28:","journal-title":"Redox Biol"},{"key":"CITATION44","doi-asserted-by":"publisher","first-page":"36412","DOI":"10.1074\/jbc.M706517200","volume":"282","author":"Lee OH","year":"2007","unstructured":"Lee OH, Jain AK, Papusha V, Jaiswal AK. An auto-regulatory loop between stress sensors INrf2 and Nrf2 controls their cellular abundance. J Biol Chem, 2007, 282: 36412-36420.","journal-title":"J Biol Chem"},{"key":"CITATION45","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1101\/gad.13.1.76","volume":"13","author":"Itoh K","year":"1999","unstructured":"Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, Yamamoto M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev, 1999, 13: 76-86.","journal-title":"Genes Dev"},{"key":"CITATION46","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.freeradbiomed.2021.05.020","volume":"171","author":"Hong J","year":"2021","unstructured":"Hong J, Shi Z, Li C, Ji X, Li S, Chen Y, Jiang G. Virtual screening identified natural Keap1-Nrf2 PPI inhibitor alleviates inflammatory osteoporosis through Nrf2-mir214-Traf3 axis. Free Radical Biol Med, 2021, 171: 365-378.","journal-title":"Free Radical Biol Med"},{"key":"CITATION47","doi-asserted-by":"publisher","first-page":"101845","DOI":"10.1016\/j.redox.2020.101845","volume":"40","author":"S\u00e1nchez-de-Diego C","year":"2021","unstructured":"S\u00e1nchez-de-Diego C, Pedrazza L, Pimenta-Lopes C, Martinez-Martinez A, Dahdah N, Valer JA, Garcia-Roves P. NRF2 function in osteocytes is required for bone homeostasis and drives osteocytic gene expression. Redox Biol, 2021, 40:","journal-title":"Redox Biol"},{"key":"CITATION48","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1101\/gad.238246.114","volume":"28","author":"Wu T","year":"2014","unstructured":"Wu T, Zhao F, Gao B, Tan C, Yagishita N, Nakajima T, Wong PK. Hrd1 suppresses Nrf2-mediated cellular protection during liver cirrhosis. Genes Dev, 2014, 28: 708-722.","journal-title":"Genes Dev"},{"key":"CITATION49","doi-asserted-by":"publisher","first-page":"12929","DOI":"10.1096\/fj.201900887RR","volume":"33","author":"Sun X","year":"2019","unstructured":"Sun X, Zhang B, Pan X, Huang H, Xie Z, Ma Y, Hu B. Octyl itaconate inhibits osteoclastogenesis by suppressing Hrd1 and activating Nrf2 signaling. FASEB J, 2019, 33: 12929-12940.","journal-title":"FASEB J"},{"key":"CITATION50","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cellsig.2011.01.014","volume":"23","author":"Yu M","year":"2011","unstructured":"Yu M, Li H, Liu Q, Liu F, Tang L, Li C, Yuan Y. Nuclear factor p65 interacts with Keap1 to repress the Nrf2-ARE pathway. Cell Signalling, 2011, 23: 883-892.","journal-title":"Cell Signalling"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/E6403066BE9040848D019971C748B578","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2022087","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/E6403066BE9040848D019971C748B578","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T08:11:07Z","timestamp":1663661467000},"score":1,"resource":{"primary":{"URL":"https:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2022087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,1]]},"references-count":50,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8,1]]},"published-print":{"date-parts":[[2022,8,1]]}},"URL":"https:\/\/doi.org\/10.3724\/abbs.2022087","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,1]]}}}